Brief: Brickell Biotech - On Aug 30, Audit Committee Said Interim Financial Statements In Co’s Report For Quarter Ended June 30, 2022 Should No Longer Be Relied Upon
01/09/2022 21:49
Sept 1 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH - ON AUG 30, AUDIT COMMITTEE SAID INTERIM
FINANCIAL STATEMENTS IN CO’S REPORT FOR QUARTER ENDED JUNE 30,
2022 SHOULD NO LONGER BE RELIED UPON
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx